Retrospectively evaluate prognosis and treatment results of patients with non small cell lung cancer

Abstract

Purpose: The purpose of this study is to review the prognostic factors and treatment results of patients with non-small cell lung cancer (NSCLC) treated in our center. Methods: The data of 238 patients with NSCLC who registered at the Radiation Oncology Department of Cumhuriyet University Medical Research and Application Hospital between at 2006-2010 were obtained from patients files. Results: This study analysed data of 238 patients. The most observed histological type was squamous cell carcinoma at 97 (41%). The 2-year survival were 84% at stage I, 76% at stage II, 34% at stage III and 9% at stage IV. The prognostic factors were age, weight loss, ECOG, thrombocytosis and high level of lactate dehydrogenase, histopathology, and stage, the use of platinum and taxan and radiation dose. Conclusion: Results of this study were that the most important prognosis factors were stage, ECOG performance status and the use of cisplatin.